Using AI to crack undruggable drug targets

Quantum technology gets a closer look at AION Labs

Insitro acquires CombinAble.AI, marking first Israeli exit for AI pharma startup

DenovAI’s physics-based bet on one-shot drug design

AION Labs to explore quantum tech

CombinAbleAI to be acquired by insitro to expand AI drug discovery platform

Israel’s biotech moment: How science, data, and geopolitics are converging – opinion

Israel’s Revolutionary Role in AI Drug Discovery –

Strongly committed to solving significant human challenges, Israel subtly leads the biotech industry

Can AI make Israel the world’s next biotech superpower?